| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 05/19/2004 | EP1419175A2 Replikin peptides and uses thereof |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418909A2 2-amino-4, 5-trisubstituted thiaolyl derivatives and their use against autoimmune diseases |
| 05/19/2004 | EP1204416A4 Carnitine analogues as topical, microbicidal spermicides |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1496742A Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 05/19/2004 | CN1496736A Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | CA2265881C Nodulisporic acid derivatives |
| 05/13/2004 | WO2003077830A3 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 05/13/2004 | WO2003070190A3 Surrogate antibodies and methods of preparation and use thereof |
| 05/13/2004 | US20040092736 Collections of compounds |
| 05/13/2004 | US20040092583 Treatment for inhibiting neoplastic lesions |
| 05/13/2004 | US20040092575 Prevent insertion of peptide into cell membranes |
| 05/13/2004 | US20040092545 Sulfonamido ether substituted imidazoquinolines |
| 05/13/2004 | US20040092515 Diaminoquinazoline esters for use as dihydrofolate reductase inhibitors |
| 05/13/2004 | US20040092490 Substituted tetracycline compounds for the treatment of malaria |
| 05/13/2004 | US20040092459 Novel macrolides |
| 05/13/2004 | US20040091894 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 05/12/2004 | EP1417234A2 Recombinant anti-plasmodium falciparum antibodies |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417185A2 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell proliferation inhibitors |
| 05/12/2004 | EP1416945A1 Improved heteropolymer complexes and methods for their use |
| 05/12/2004 | EP1416941A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496348A 5-cyano-1H-indole derivatives as antagonists of interleukine-8 receptors |
| 05/12/2004 | CN1495183A Para-herqueinamide as medicine for resisting parasite |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/11/2004 | CA2312898C Long acting injectable formulations containing hydrogenated castor oil |
| 05/11/2004 | CA2099569C New a83543 compounds and process for production thereof |
| 05/06/2004 | WO2004022041A3 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 05/06/2004 | WO2003097604A9 Pyridine carboxamide derivatives and their use as pesticides |
| 05/06/2004 | WO2003051304A3 Bioadhesive drug delivery system with enhanced gastric retention |
| 05/06/2004 | WO2003005971A8 Tetracycline compounds having target therapeutic activities |
| 05/06/2004 | WO2002022150A3 Medicament containing activated antithrombin iii |
| 05/06/2004 | US20040087618 Halogen-substituted quinoline derivatives and ectoparasite control agent |
| 05/06/2004 | US20040087592 Treatment of malaria with farnesyl protein transferase inhibitors |
| 05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
| 05/06/2004 | US20040087552 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/06/2004 | US20040087538 Nucleic acids containing unmethylated cytosine-guanine dinucleotides activate lymphocytes and redirect an immune response from th2 to th1 |
| 05/06/2004 | US20040087519 Avermectin derivatives |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086540 Topically administering to an area on the subject where ectoparasites are present a composition comprising a fatty acid ester and at least 20% cyclic siloxane |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1414967A2 Gene associated with leishmania parasite virulence |
| 05/06/2004 | EP1414861A2 Humanized antibodies against icam-1, their production and uses |
| 05/06/2004 | EP1414813A1 1,2,4-trioxolane antimalarials |
| 05/06/2004 | EP1414495A1 Anti-microbial targeting chimeric pharmaceutical |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/05/2004 | CN1494424A IL-8 receptor antagonists |
| 05/05/2004 | CN1148448C DNA for coding complete malaria antigene gp 190/MSP1, preparing process and use thereof |
| 05/05/2004 | CN1148378C 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035591A1 Anthelmintic and insecticidal thiohene compositions |
| 04/29/2004 | WO2004035021A2 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003101996A8 Esters in position 20 of camptothecins |
| 04/29/2004 | WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 04/29/2004 | WO2003009812A3 Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| 04/29/2004 | WO2003004683A3 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082757 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 04/29/2004 | US20040082624 Organic compounds |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082549 Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections |
| 04/29/2004 | US20040082527 Selected from the group of form D and E, F, G, J, M in the absence of azithromycin dihydrate, N, O, P, Q, and R; nuclear magnetic resonance spectrum analysis; bactericides; antiprotozoa agents; infections of mammals, birds and fish; drug resistance |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081971 Gastrointestinal disorders; cardiovascular disorders; autoimmune diseases; cell proliferation; antiinflammatory agents |
| 04/29/2004 | US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent |
| 04/29/2004 | US20040081654 Use of plant oil-bodies in vaccine delivery systems |
| 04/29/2004 | CA2502516A1 Anthelmintic and insecticidal thiophene compositions |
| 04/29/2004 | CA2497262A1 Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| 04/28/2004 | EP1413582A1 Dimeric pyrrolobenzodiazepines |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1413201A2 Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 04/28/2004 | EP1412380A1 New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialis |
| 04/28/2004 | EP1411985A1 Treatment of parasitic disease |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | CN1147475C Process for preparation of anti-malarial drugs |
| 04/28/2004 | CN1147232C Antiparasitic formulations |
| 04/27/2004 | US6727352 Methods of making macrolides |
| 04/27/2004 | US6727228 Mixture containing pesticide and stabilizer |
| 04/27/2004 | CA2104214C Cytokine inhibitors |
| 04/22/2004 | WO2004032953A1 Treatment of allergic conditions by use of il 21 |
| 04/22/2004 | WO2004032629A1 Mixed compositions for controlling parasitic insects |
| 04/22/2004 | WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/22/2004 | WO2003057722A3 Cyclic tetrapeptide compound and use thereof |
| 04/22/2004 | WO2000061134A9 Antimicrobial agents |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077678 Urea substituted imidazoquinoline ethers |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | CA2501807A1 Treatment of allergic conditions by use of il 21 |
| 04/22/2004 | CA2501767A1 Mixture compositions for controlling ectoparasites |